TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Integrated Diagnostics Holdings ( (GB:IDHC) ) has shared an announcement.
Integrated Diagnostics Holdings announced it will release its unaudited financial results for Q3 and the nine-month period ending September 30, 2025, on November 13, 2025. This announcement is significant for stakeholders as it reflects the company’s ongoing financial performance and strategic positioning in the diagnostics industry, particularly in the Middle East and Africa, where it continues to expand its operations and market presence.
More about Integrated Diagnostics Holdings
Integrated Diagnostics Holdings (IDH) is a prominent diagnostics services provider in the Middle East and Africa, offering a wide range of clinical pathology and radiology tests across Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan. With over 40 years of experience, IDH operates through core brands such as Al Borg, Al Borg Scan, and Al Mokhtabar in Egypt, Biolab in Jordan, Echo-Lab in Nigeria, and others. The company is known for its quality and safety standards, serving millions of patients through its extensive network of branches, and is listed on the London Stock Exchange.
Average Trading Volume: 205,957
Technical Sentiment Signal: Buy
Current Market Cap: $325.5M
See more data about IDHC stock on TipRanks’ Stock Analysis page.